Rest of World — Cost of Sales
Edwards Lifesciences Rest of World — Cost of Sales increased by 3.3% to $47.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 19.6%, from $39.80M to $47.60M. Over 3 years (FY 2022 to FY 2025), Rest of World — Cost of Sales shows an upward trend with a 13.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase relative to sales may indicate rising manufacturing costs, supply chain inefficiencies, or unfavorable currency impacts, while a decrease suggests improved production efficiency or favorable product mix.
Detailed definition
This metric captures the direct costs associated with manufacturing, shipping, and distributing medical devices sold wit...
Peer comparison
Comparable to 'Cost of Goods Sold' (COGS) allocated to specific international business segments at peer medical technology firms.
ew_segment_rest_of_world_cost_of_salesHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $29.55M | $29.55M | $29.55M | $29.55M | $34.05M | $34.05M | $34.05M | $34.05M | $38.40M | $40.30M | $41.00M | $38.40M | $39.80M | $43.90M | $40.80M | $46.10M | $47.60M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +15.2% | +0.0% | +0.0% | +0.0% | +12.8% | +4.9% | +1.7% | -6.3% | +3.6% | +10.3% | -7.1% | +13.0% | +3.3% |
| YoY Change | — | — | — | — | +15.2% | +15.2% | +15.2% | +15.2% | +12.8% | +18.4% | +20.4% | +12.8% | +3.6% | +8.9% | -0.5% | +20.1% | +19.6% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's rest of world — cost of sales?
- Edwards Lifesciences (EW) reported rest of world — cost of sales of $47.60M in Q1 2026.
- How has Edwards Lifesciences's rest of world — cost of sales changed year-over-year?
- Edwards Lifesciences's rest of world — cost of sales increased by 19.6% year-over-year, from $39.80M to $47.60M.
- What is the long-term trend for Edwards Lifesciences's rest of world — cost of sales?
- Over 3 years (2022 to 2025), Edwards Lifesciences's rest of world — cost of sales has grown at a 13.0% compound annual growth rate (CAGR), from $118.20M to $170.60M.
- What does rest of world — cost of sales mean?
- The direct costs incurred to produce and deliver products sold in the Rest of World geographic segment.